Opportunity Information: Apply for RFA OD 10 001

  • The National Institutes of Health in the health recovery act sector is offering a public funding opportunity titled "ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Clinical Trials (RC4)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.701 Trans NIH Recovery Act Research Support.
  • This funding opportunity was created on Dec 28, 2009 and posted on Dec 28, 2009.
  • Applicants must submit their applications by Apr 7, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 2 candidate(s).
  • Eligible applicants include: Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) State governments County governments Small businesses Public and State controlled institutions of higher education Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments For profit organizations other than small businesses Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for RFA OD 10 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Clinical Trials (RC4) grant opportunity (Funding Opportunity Number RFA-OD-10-001) was a National Institutes of Health (NIH) funding announcement backed by American Recovery and Reinvestment Act of 2009 (ARRA) funds, with additional support tied to the Agency for Healthcare Research and Quality (AHRQ). Its central goal was to fund rigorous clinical trials that test whether behavioral economics based "nudges" can measurably increase how often health care providers actually use findings from comparative effectiveness research (CER) in day-to-day clinical practice. The motivation is straightforward: even when CER identifies treatments, procedures, or care pathways that appear superior, real-world adoption by clinicians and health systems is often slower and smaller than expected. This FOA treated that implementation gap as a practical, high-impact research problem and asked applicants to address it with experimentally tested behavioral interventions rather than relying only on education, guidelines, or financial incentive programs.

A defining requirement of the opportunity was that applicants propose controlled trials with random assignment, meaning the project needed to be designed as either a randomized clinical trial (RCT) or a cluster randomized trial (CRT). Randomization could occur at the individual level (for example, individual clinicians) or at a clustered level such as practices, hospitals, or even larger organizational units. In other words, this was not a request for observational research, descriptive implementation reports, or purely qualitative studies. The program was specifically focused on testing causal effects of behavioral economics strategies on provider behavior and uptake of CER-backed practices, using experimental designs strong enough to produce credible, decision-ready evidence.

The research theme centered on behavioral economics, described here as an interdisciplinary approach blending insights from psychology, decision science, and economics to reflect how people actually make decisions, rather than assuming perfectly rational behavior. The FOA explicitly linked this perspective to classic work like Kahneman and Tversky's Prospect Theory and later contributions emphasizing predictable decision biases, framing effects, defaults, and other features of real-world choice. For this grant, the practical implication was that provider decisions might be shifted by altering choice architecture: changing defaults in ordering systems, adjusting how options are framed, simplifying decisions, using timely prompts, leveraging social norms, or otherwise designing environments that make evidence-aligned actions easier and more likely. The announcement also pointed out that some nudges, particularly default-based approaches, could potentially deliver behavior change at lower cost than traditional strategies such as some pay-for-performance (P4P) arrangements, which can be expensive, administratively complex, and uneven in effectiveness.

On the CER side, the FOA required that the meaning of "comparative effectiveness research" follow the Federal Coordinating Council definition referenced in the HHS Recovery Act CER annual report. Practically, that meant the targeted behaviors and clinical decisions in the proposed trials needed to be tied to credible CER findings comparing interventions, tests, or delivery strategies, and the goal was to increase real implementation of what CER suggests works better for patients in relevant settings. The intended end result was higher-quality care driven by stronger alignment between everyday practice and the best available comparative evidence.

Administratively, this was a discretionary grant program under the Health category, using a grant funding instrument. The NIH anticipated making about 2 awards, with an estimated total funding level of $15,000,000. There was no cost sharing or matching requirement, which matters because it reduced barriers for applicants that might not have had institutional capacity to provide matching funds. Key dates reflected the Recovery Act timeline: it was posted and created on December 28, 2009, with an original and current closing date of April 7, 2010, and an archive date of May 8, 2010.

Eligibility was broad and inclusive across government, academic, nonprofit, and private sectors. Eligible applicants included state, county, city or township governments, special district governments, independent school districts, and U.S. territories or possessions. It also included public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with and without 501(c)(3) status, small businesses, and other for-profit organizations (excluding small businesses in that specific category listing, though other for-profits were allowed). The opportunity also explicitly included tribal governments and tribal organizations, public housing authorities and Indian housing authorities, and a range of mission-focused institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities (TCCUs). Faith-based and community-based organizations were listed as eligible, and certain federal entities were also included under "Eligible Agencies of the Federal Government." Taken together, the eligibility structure signaled an intent to fund trials in real clinical environments and delivery systems, not only in traditional academic medical centers.

In practical terms, a competitive application under this FOA would have been expected to identify a specific CER-supported practice change (for example, choosing a preferred medication, appropriate imaging use, evidence-aligned preventive care workflows, or other clinician behaviors), design a behavioral economics intervention that directly targets known decision frictions, and then evaluate it using a randomized design with appropriate outcomes. Outcomes would likely include measurable provider behaviors (ordering, prescribing, referral patterns, adherence to protocols) and potentially downstream patient or system outcomes when feasible, along with attention to scalability and cost-effectiveness given the FOA's emphasis on potentially lower-cost nudging approaches.

The complete announcement was hosted through the NIH grants guide (link provided in the source), and the contact listed for access or technical issues was the NIH Office of Extramural Research (OER) webmaster.

Frequently Asked Questions (FAQs)

What is the ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Clinical Trials (RC4) opportunity?

It was a National Institutes of Health (NIH) funding announcement supported by American Recovery and Reinvestment Act of 2009 (ARRA) funds, with additional support tied to the Agency for Healthcare Research and Quality (AHRQ). The Funding Opportunity Number (FON) was RFA-OD-10-001.

What problem was this funding opportunity trying to solve?

The program focused on the real-world implementation gap: even when comparative effectiveness research (CER) identifies better treatments, procedures, or care pathways, uptake by clinicians and health systems can be slower and smaller than expected. The opportunity treated that gap as a practical research problem and asked applicants to test behavioral interventions designed to increase provider use of CER findings in routine clinical care.

What was the main goal of the funded projects?

To fund rigorous clinical trials that test whether behavioral economics-based "nudges" can measurably increase how often health care providers use CER-supported practices in day-to-day clinical practice.

What kinds of study designs were required?

Applicants had to propose controlled trials with random assignment. Projects needed to be designed as randomized clinical trials (RCTs) or cluster randomized trials (CRTs).

Could randomization be done at different levels?

Yes. Randomization could be at the individual level (such as individual clinicians) or at a cluster level (such as practices, hospitals, or larger organizational units).

Were observational or descriptive implementation studies allowed?

No. The announcement was not seeking observational research, descriptive implementation reports, or purely qualitative studies. It specifically emphasized experimental designs intended to test causal effects of behavioral economics strategies on provider behavior.

What did the FOA mean by "behavioral economics"?

Behavioral economics was described as an interdisciplinary approach combining psychology, decision science, and economics to reflect how people actually make decisions rather than assuming fully rational behavior. The announcement explicitly connected this perspective to classic work such as Kahneman and Tversky's Prospect Theory and later work on predictable decision biases.

What are examples of "nudges" or behavioral economics strategies referenced in the opportunity?

The FOA emphasized changing "choice architecture" to make evidence-aligned actions easier and more likely. Examples included altering defaults in ordering systems, changing how options are framed, simplifying decisions, using timely prompts, leveraging social norms, and designing environments that steer decisions toward evidence-supported choices.

Why did the FOA emphasize nudges instead of only using education, guidelines, or financial incentives?

The opportunity highlighted that nudges (especially default-based approaches) could potentially achieve behavior change at lower cost than traditional strategies such as some pay-for-performance (P4P) arrangements, which can be expensive, administratively complex, and uneven in effectiveness.

What did the opportunity require regarding comparative effectiveness research (CER)?

The targeted clinical behaviors and decisions in proposed trials needed to be tied to credible CER findings comparing interventions, tests, or delivery strategies, with the aim of increasing implementation of what CER suggests works better for patients in relevant settings.

How was "comparative effectiveness research" defined for this opportunity?

The FOA required that CER follow the Federal Coordinating Council definition referenced in the HHS Recovery Act CER annual report.

What types of outcomes were applicants expected to measure?

While specific measures would depend on the proposed trial, the FOA emphasized measurable provider behaviors and uptake of CER-backed practices. Examples included ordering, prescribing, referral patterns, and adherence to protocols. It also suggested attention to scalability and cost-effectiveness, and potentially downstream patient or system outcomes when feasible.

How many awards did NIH expect to make and what was the total estimated funding?

NIH anticipated making about 2 awards, with an estimated total funding level of $15,000,000.

Was cost sharing or matching required?

No. The opportunity stated there was no cost sharing or matching requirement.

What type of funding mechanism was used?

It was a discretionary grant program under the Health category, using a grant funding instrument.

What were the key dates for this funding opportunity?

It was posted and created on December 28, 2009. The original and current closing date was April 7, 2010. The archive date was May 8, 2010.

Who was eligible to apply?

Eligibility was broad and included government, academic, nonprofit, and private sector organizations. Examples listed included state, county, city or township governments; special district governments; independent school districts; U.S. territories or possessions; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with and without 501(c)(3) status; small businesses; and other for-profit organizations (with small businesses also explicitly included in the listing).

Did the eligibility list include tribal entities?

Yes. Tribal governments, tribal organizations, and Tribally Controlled Colleges and Universities (TCCUs) were explicitly included.

Were public housing authorities eligible?

Yes. Public housing authorities and Indian housing authorities were listed as eligible applicants.

Were faith-based and community-based organizations eligible?

Yes. Faith-based and community-based organizations were explicitly listed as eligible.

Did the opportunity include mission-focused higher education institutions (HBCUs, HSIs, etc.)?

Yes. The eligibility list included Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, and related categories such as TCCUs.

Could federal entities apply?

Yes. Certain federal entities were included under "Eligible Agencies of the Federal Government."

What did NIH appear to be encouraging through its broad eligibility?

Based on the eligibility structure and the emphasis on implementation, the announcement signaled interest in trials conducted in real clinical environments and delivery systems, not only in traditional academic medical centers.

What would a competitive application have been expected to include?

The FOA description suggests a competitive application would identify a specific CER-supported practice change, design a behavioral economics intervention targeting known decision frictions, and evaluate the intervention using a randomized design with appropriate outcome measures.

Where was the full announcement hosted?

The complete announcement was hosted through the NIH grants guide (a link was provided in the source description).

Who was listed as the contact for access or technical issues?

The NIH Office of Extramural Research (OER) webmaster was listed as the contact for access or technical issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health Recovery Act

Next opportunity: ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Pilot Research (RC4)

Previous opportunity: COMBATING TRAFFICKING IN PERSONS (CTIP)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA OD 10 001

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA OD 10 001) also looked into and applied for these:

Funding Opportunity
ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Pilot Research (RC4) Apply for RFA OD 10 002

Funding Number: RFA OD 10 002
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $500,000
Recovery Act Limited Competition Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease, Eradication Methods for Methicillin Resistant Staphylococcus aureus and Dementia Detection and Management Strategies (RC4) Apply for RFA OD 10 008

Funding Number: RFA OD 10 008
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $500,000
Recovery Act Limited Competition NIH Directors Opportunity for Research in Five Thematic Areas (RC4) Apply for RFA OD 10 005

Funding Number: RFA OD 10 005
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: Case Dependent
Recovery Act Limited Competition Methodology Development in Comparative Effectiveness Research (RC4) Apply for RFA OD 10 009

Funding Number: RFA OD 10 009
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $500,000
Recovery Act Limited Competition Research On Biosamples From Selected Diabetes Clinical Studies (RC4) Apply for RFA OD 10 010

Funding Number: RFA OD 10 010
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA OS Recovery Act 2009 Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18) Apply for RFA AE 10 001

Funding Number: RFA AE 10 001
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: Case Dependent
Recovery Act Limited Competition Institutional Comparative Effectiveness Research Mentored Career Development Award (KM1) Apply for RFA OD 10 011

Funding Number: RFA OD 10 011
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA OS Recovery Act 2009 Limited Competition Enhanced Registries for Quality Improvement and Comparative Effectiveness Research (R01) Apply for RFA HS 10 020

Funding Number: RFA HS 10 020
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: $4,000,000
Recovery Act Limited Competition Framework Programs for Global Health Signature Innovations Initiative (R24) Apply for RFA OD 10 007

Funding Number: RFA OD 10 007
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $250,000
Recovery Act Limited Competition Program to Enhance NIH supported Global Health Research Involving Human Subjects (S07) Apply for RFA OD 10 006

Funding Number: RFA OD 10 006
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $50,000
ARRA OS Recovery Act 2009 Limited Competition Accelerating Implementation of Comparative Effectiveness Findings on Clinical and Delivery System Interventions by Leveraging AHRQ Networks (R18) Apply for RFA HS 10 014

Funding Number: RFA HS 10 014
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: $16,660,000
ARRA OS Recovery Act 2009 Limited Competition Comparative Effectiveness Delivery System Evaluation Grants (R01) Apply for RFA HS 10 012

Funding Number: RFA HS 10 012
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: $500,000
ARRA OS Recovery Act 2009 Limited Competition Comparative Effectiveness Delivery System Demonstration Grants (R18) Apply for RFA HS 10 013

Funding Number: RFA HS 10 013
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA OS Recovery Act 2009 Limited Competition Enhanced State Data for Analysis and Tracking of Comparative Effectiveness Impact Improved Clinical Content and Race Ethnicity Data (R01) Apply for RFA HS 10 010

Funding Number: RFA HS 10 010
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: Case Dependent
Recovery Act Limited Competition The NIH Directors ARRA Funded Pathfinder Award to Promote Diversity in the Scientific Workforce (DP4) Apply for RFA OD 10 013

Funding Number: RFA OD 10 013
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $2,000,000
2010 ARRA Prevention and Wellness Leveraging National Organizations Apply for OS PAW 10 001

Funding Number: OS PAW 10 001
Agency: Office of the Assistant Secretary for Health
Category: Health Recovery Act
Funding Amount: $1,500,000
ARRA Training in Primary Care Medicine Interdisciplinary and Interprofessional Joint Graduate Degree Apply for HRSA 10 236

Funding Number: HRSA 10 236
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA Training in Primary Care Medicine Physician Assistant Training in Primary Care Apply for HRSA 10 234

Funding Number: HRSA 10 234
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA Training in Primary Care Medicine Predoctoral Training in Primary Care Apply for HRSA 10 233

Funding Number: HRSA 10 233
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA Training in Primary Care Medicine Physician Faculty Development in Primary Ca Apply for HRSA 10 232

Funding Number: HRSA 10 232
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 10 001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.